Information  X 
Enter a valid email address

Avacta Group PLC Ord 10P (AVCT)

Date Time Source Announcement
16 May 2022 12:00 pm
RNS
AffyXell expands partnership with GenScript ProBio
11 May 2022 7:00 am
RNS
London Therapeutics headquarters established
06 May 2022 7:00 am
RNS
Block Listing Application to AIM (update)
28 Apr 2022 1:53 pm
RNS
Block Listing Application to AIM
14 Apr 2022 5:01 pm
RNS
Issue of Equity and Total Voting Rights
  11:29 am
RNS
Issue of Equity and Total Voting Rights
13 Apr 2022 7:00 am
RNS
AffyXell milestone and increased equity stake
12 Apr 2022 7:00 am
RNS
Poster presented at the AACR available to download
11 Apr 2022 4:41 pm
RNS
Second Price Monitoring Extn
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
08 Apr 2022 1:57 pm
RNS
Issue of Equity and Total Voting Rights
  7:00 am
RNS
AffyXell partners with Biocytogen and KNTSC
07 Apr 2022 4:31 pm
RNS
Issue of Equity and Total Voting Rights
06 Apr 2022 7:00 am
RNS
Preliminary Results
30 Mar 2022 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Notice of Results and Investor Presentation
29 Mar 2022 7:00 am
RNS
AVA6000 data poster presentation at AACR
21 Mar 2022 7:00 am
RNS
Directorate Change
16 Mar 2022 7:00 am
RNS
Vimian acquires Avacta's Animal Health Division
14 Feb 2022 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
07 Feb 2022 4:36 pm
RNS
Price Monitoring Extension
03 Feb 2022 5:26 pm
RNS
Issue of Equity and Total Voting Rights
  4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Dose escalation in the phase I trial of AVA6000
31 Jan 2022 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
18 Jan 2022 7:00 am
RNS
Second pre|CISION Pro-drug Candidate Selected
12 Jan 2022 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
10 Jan 2022 7:00 am
RNS
Update on AffiDX and detection of Omicron variant
04 Jan 2022 11:06 am
RNS
Second Price Monitoring Extn
  11:01 am
RNS
Price Monitoring Extension
22 Dec 2021 4:26 pm
RNS
Issue of Equity and Total Voting Rights
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
AffiDX Receives CE Mark for Consumer Self-Testing
16 Dec 2021 7:00 am
RNS
Issue of Equity and Total Voting Rights
15 Dec 2021 7:00 am
RNS
AffiDx? lateral flow test detects Omicron variant
  7:00 am
RNS
Change of auditor
29 Nov 2021 7:00 am
RNS
FDA Approval of IND Application for AVA6000
18 Nov 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
02 Nov 2021 7:00 am
RNS
Update on UK Availability of AffiDX Test
14 Oct 2021 4:36 pm
RNS
Price Monitoring Extension
  12:36 pm
RNS
Issue of Equity and Total Voting Rights
30 Sep 2021 7:00 am
RNS
Interim Results for the Period Ended 30 June 2021
29 Sep 2021 7:00 am
RNS
Development Milestone in LG Chem Partnership
22 Sep 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
09 Sep 2021 7:00 am
RNS
Notice of Results
06 Sep 2021 7:00 am
RNS
New appointments to Scientific Advisory Board
02 Sep 2021 7:00 am
RNS
Appointment of Chief Scientific Officer
25 Aug 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
18 Aug 2021 7:00 am
RNS
Directorate Change
11 Aug 2021 7:00 am
RNS
First Patient Dosed in AVA6000 Phase 1 Trial

a d v e r t i s e m e n t